Literature DB >> 35589138

Phosphaturic Mesenchymal Tumor.

J C Benson1, J A Trejo-Lopez2, A M Nassiri3, K Eschbacher2, M J Link4, C L Driscoll3, R D Tiegs5, J Sfeir5, D R DeLone6.   

Abstract

Phosphaturic mesenchymal tumors (PMTs) are neoplasms associated with tumor-induced osteomalacia. Patients typically present with pathologic fractures in the setting of chronic hypophosphatemic hyperphosphaturic osteomalacia, as well as gradual muscle weakness, bone pain, and difficulty walking. Because of their rarity and nonspecific symptomatology, phosphaturic mesenchymal tumors often go undiagnosed for years. Even when discovered on imaging, the tumors can be diagnostically challenging for radiologists. Phosphaturic mesenchymal tumors often tend to be small and can be located nearly anywhere in the body, and, therefore, can mimic many other tumors. This case highlights the imaging and pathologic markers of a phosphaturic mesenchymal tumor, often found in a patient with tumor-induced osteomalacia.
© 2022 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2022        PMID: 35589138      PMCID: PMC9172954          DOI: 10.3174/ajnr.A7513

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  30 in total

1.  Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.

Authors:  J C Horng; E Van Eperen; S Tutton; R Singh; J L Shaker; A N Wooldridge
Journal:  Osteoporos Int       Date:  2021-03-02       Impact factor: 4.507

Review 2.  Phosphaturic mesenchymal tumors: A review and update.

Authors:  Andrew L Folpe
Journal:  Semin Diagn Pathol       Date:  2019-07-05       Impact factor: 3.464

3.  RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.

Authors:  Armita Bahrami; Sharon W Weiss; Elizabeth Montgomery; Andrew E Horvai; Long Jin; Carrie Y Inwards; Andrew L Folpe
Journal:  Am J Surg Pathol       Date:  2009-09       Impact factor: 6.394

Review 4.  Oncogenic osteomalacia.

Authors:  Kelli Andresen Edmister; Murali Sundaram
Journal:  Semin Musculoskelet Radiol       Date:  2002-09       Impact factor: 1.777

5.  Phosphaturic mesenchymal tumor of the nasal cavity and paranasal sinuses: A clinical curiosity presenting a diagnostic challenge.

Authors:  Shubhada V Kane; Aanchal Kakkar; Nikita Oza; Epari Sridhar; Prathamesh S Pai
Journal:  Auris Nasus Larynx       Date:  2017-06-01       Impact factor: 1.863

6.  Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss.

Authors:  Amir Ghorbani-Aghbolaghi; Morgan Angus Darrow; Tao Wang
Journal:  Autops Case Rep       Date:  2017-09-30

7.  Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report.

Authors:  Shui Qiu; Li-Li Cao; Yue Qiu; Ping Yan; Zi-Xuan Li; Jiang Du; Li-Mei Sun; Qing-Fu Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Weibo Xia; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

9.  Phosphaturic mesenchymal tumor: Case report.

Authors:  Adam L Richardson; Olivia K Richardson
Journal:  Radiol Case Rep       Date:  2019-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.